Several lipid‐sensitive nuclear receptors such as liver X receptors/retinoid X receptors (LXR/RXR), PPARγ, and PPARα have been associated with AD pathology and are potential therapeutic targets [9]. The gene discussed is PPARA; the disease is Alzheimer disease.